Wolverine Trading
VIVE

Wolverine Trading’s VIVEVE MED INC VIVE Stock Holding History

Wolverine Trading’s Portfolio VIVE Stock Details VIVE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-33
Closed -$122K – 6163
2018
Q2 		$122K Hold
33
– – ﹤0.01% 4642
2018
Q1 		$122K Buy
+33
New +$144K ﹤0.01% 4642

Other funds holding VIVE

NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PC
Polar Capital London, United Kingdom $13.5B AUM 55.9% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
MIH
Meitav Investment House Bene-Beraq, Israel $9.12B AUM 42.07% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Wolverine Trading's VIVE Position: Q3 2018 in Review

Wolverine Trading sold out of VIVEVE MED INC (VIVE) in Q3 2018, closing a stake of 33 shares — an estimated $122K sold.

Wolverine Trading first reported a position in VIVE in Q1 2018 and held it in 2 quarters. The position peaked at $122K in Q2 2018. 36 funds tracked by Wall St. Rank hold VIVE as of Q3 2018.

  • Wolverine Trading reported no remaining VIVEVE MED INC position as of Q3 2018 after selling out during the quarter.
  • Wolverine Trading sold 33 VIVEVE MED INC shares in Q3 2018, an estimated $122K.
  • Wolverine Trading first reported a position in VIVEVE MED INC in Q1 2018 and held it in 2 quarters.
  • Wolverine Trading's VIVEVE MED INC position peaked at $122K in Q2 2018.
  • 36 funds tracked by Wall St. Rank held VIVEVE MED INC as of Q3 2018.

Based on Wolverine Trading's 13F filing for Q3 2018, filed 14 Nov 2018.